Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-14

FDA Approved: LEVETIRACETAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for levetiracetam from Lupin Pharmaceuticals, expanding/modifying the labeling for this product. This likely reflect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)